Insider Purchases: Inside the Buy

Tag: risks buying ELV

A polished editorial illustration depicting a mountain trail leading toward a modern hospital campus at sunrise. In the foreground, a confident female CEO in business attire reviews a stock chart while holding a healthcare blueprint.

🏥 Elevance Health (NYSE: ELV): The CEO Bought Again. We're Still Buying the Story.

Exactly one year after publishing our original bullish thesis on Elevance Health, we're revisiting the story. Shares are up nearly 26%, yet the core investment case remains surprisingly intact. CEO Gail Boudreaux just bought another $1 million worth of stock, institutions continue to hold over 93% of shares, and valuation still looks attractive.

Read entire article

Tags: buy or sell ELV, Carelon, Elevance Health, ELV, featured-insiders, FUNanc1al, FUNStock Index, Gail Boudreaux, Health Insurance, Healthcare Stocks, hub-insiders, Insider Buying, Insider Purchases, Long-Term Investing, Managed Care, NYSE, risks buying ELV, Stock Analysis, Value Investing, Why buy ELV